Ubs Group Ag Amarin Corp Plcuk Call Options Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 01, 2020
SELL
$4.0 - $21.53 $540,000 - $2.91 Million
-135,000 Reduced 42.86%
180,000 $720,000
Q4 2019

Feb 14, 2020
BUY
$13.94 - $24.12 $3.35 Million - $5.79 Million
240,000 Added 320.0%
315,000 $6.75 Million
Q2 2019

Aug 14, 2019
BUY
$16.27 - $20.51 $1.22 Million - $1.54 Million
75,000 New
75,000 $1.45 Million

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $185M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email